Roche Media 18 nov. 2025 Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline #Clinical Trials #Oncology Pipeline
Roche Media 18 nov. 2025 Roche reports positive Phase III data of giredestrant for breast cancer - Clinical Trials Arena #Phase III #Clinical Trials
Roche Media 11 nov. 2025 Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena #Phase III #Clinical Trials
Roche Media 3 nov. 2025 Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena #Phase III #III trial
Roche Media 23 sept. 2025 Roche pushes a novel myeloma target | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline #Clinical Trials #Oncology Pipeline
Roche Media 23 sept. 2025 Roche looks earlier with divarasib | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline #Clinical Trials #Oncology Pipeline
Roche Media 24 juil. 2025 5,000 patients later Roche scraps its TIGIT | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline #Clinical Trials #Oncology Pipeline